COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy, Safety and Immunogenicity Study of SARS-CoV-2 Inactivated Vaccine (COVID-19)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04508075
Recruitment Status : Recruiting
First Posted : August 11, 2020
Last Update Posted : August 21, 2020
Sponsor:
Collaborators:
Faculty of Medicine Universitas Padjadjaran
National Intitute of Health Research and Development, Ministry of Health Republic of Indonesia
Sinovac Life Sciences Co., Ltd.
Information provided by (Responsible Party):
PT Bio Farma

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 2021
Estimated Study Completion Date : September 2021